Neurocrine Biosciences Stock Forecast
Weaker technical forecast for Neurocrine Biosciences as stock downgraded to Hold/Accumulate.
(Updated on Jul 02, 2024)
The Neurocrine Biosciences stock price fell by -1.87% on the last day (Tuesday, 2nd Jul 2024) from $140.11 to $137.49. During the last trading day the stock fluctuated 1.56% from a day low at $136.92 to a day high of $139.05. The price has risen in 6 of the last 10 days and is up by 1.63% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -56 thousand shares and in total, 704 thousand shares were bought and sold for approximately $96.77 million.
The stock is moving within a horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Neurocrine Biosciences stock with a 90% probability to be traded between $128.76 and $138.13 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
NBIX Signals & Forecast
The Neurocrine Biosciences stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $136.30 and $136.79. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, July 01, 2024, and so far it has fallen -1.87%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
Support, Risk & Stop-loss for Neurocrine Biosciences stock
Neurocrine Biosciences finds support from accumulated volume at $134.62 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved $2.13 between high and low, or 1.56%. For the last week the stock has had daily average volatility of 2.52%.
Our recommended stop-loss: $131.67 (-4.23%) (This stock has low daily movements and this gives low risk. There is a sell signal from a pivot top found 9 days ago.)
Trading Expectations (NBIX) For The Upcoming Trading Day Of Wednesday 3rd
For the upcoming trading day on Wednesday, 3rd we expect Neurocrine Biosciences to open at $137.82, and during the day (based on 14 day Average True Range), to move between $133.79 and $141.19, which gives a possible trading interval of +/-$3.70 (+/-2.69%) up or down from last closing price. If Neurocrine Biosciences takes out the full calculated possible swing range there will be an estimated 5.38% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $137.67 (0.13%) than the support at $134.62 (2.09%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Neurocrine Biosciences stock A Buy?
Neurocrine Biosciences holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.
Current score: -0.011 Hold/Accumulate Downgraded
Predicted Opening Price for Neurocrine Biosciences of Wednesday, July 3, 2024
| Fair opening price July 3, 2024 | Current price |
|---|---|
| $137.82 ( 0.239%) | $137.49 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for NBIX
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 139.95 | 1.79% |
| R2 | 139.14 | 1.20% |
| R1 | 138.63 | 0.83% |
| Price | 137.49 | |
| S1 | 137.00 | -0.354% |
| S2 | 136.50 | -0.720% |
| S3 | 135.68 | -1.31% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 143.03 | 4.03% |
| R2 | 140.09 | 1.89% |
| R1 | 137.67 | 0.131% |
| Price | 137.49 | |
| S1 | 134.62 | -2.09% |
| S2 | 134.57 | -2.12% |
| S3 | 133.48 | -2.92% |
FAQ
Click here for our free guide on how to buy Neurocrine Biosciences Stock.
